2025 MCM | After ESMO 2024: What Novel Therapies Are in Use and on Development for Pancreas and Biliary Cancers?

2025 MCM | After ESMO 2024: What Novel Therapies Are in Use and on Development for Pancreas and Biliary Cancers?

0% Complete

Course Content

Credits

  • AMA PRA Category 1 Creditâ„¢Non-CME

Course Details

Duration
0.00 hour
Released
Jun 24, 2025
Last Review
Jun 24, 2025
Expires
Jun 24, 2026

Target Audience

Physicians

Nurses

Pharmacists

Physician Associates

Faculty & Disclosure

Faculty

Caio Max Rocha-Lima, MD, MS

Disclosure

Caio Max Rocha-Lima, MD, MS

Accreditation

NA